Back to News & Events

Applied Research and Development Awards Announced

The Center for Biotechnology has announced the recipients of the 2016-2017 Applied Research & Development (ARAD) awards. The ARAD Program is designed to help bridge the gap between the early-stage technology discovery and development capabilities of the academic community and the later-stage commercial development interests of the bioscience industry.

The program currently provides matching funds on a competitive basis to support collaborations between Stony Brook University faculty and NY State corporate partners in all areas of medical biotechnology. The primary interest is in supporting development of technologies that will help companies hit commercially relevant milestones, and that have the potential to positively impact the New York State economy. The projects funded include:

  • ICU Temporary Pacemaker – Dr. Wei Lin and Avery Biomedical Device, Inc.
  • Novel Synergistic and Pleiotropic Skin Brightening Agents – Dr. Sanford Simon and Biocogent, LLC
  • Continued In vivo Testing of Vaccine Candidates – Dr. Eckard Wimmer and Cogadenix, Inc.
  • Advanced Fistula-in-Ano Treatment Device – Dr. Tom Zimmerman and Pepper5, Inc.
  • Development of Nanoemulsion-PUFA-taxoids as Tumor-Targeted Chemotherapeutics – Dr. Iwao Ojima and TargaGenix, Inc.
  • Initial Pre-Clinical Safety Assessment of TRB-N0224 – Dr. Lorne Golub and Traverse Biosciences, Inc.
  • Evaluation of a Continuous Visible Light Disinfection System’s Ability to Reduce Bioburden and Subsequently the Incidence of Infections and Colonizations in an Active Patient Area – Dr. Annie Rohan and Vital Vio, Inc.

More information about the Applied Research & Development (ARAD) program, as well as all Center for Biotechnology Technology Development programs can be found here.

Related Stories

WP_Query Object
(
    [query] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
        )

    [query_vars] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
            [error] => 
            [m] => 
            [p] => 0
            [post_parent] => 
            [subpost] => 
            [subpost_id] => 
            [attachment] => 
            [attachment_id] => 0
            [name] => 
            [pagename] => 
            [page_id] => 0
            [second] => 
            [minute] => 
            [hour] => 
            [day] => 0
            [monthnum] => 0
            [year] => 0
            [w] => 0
            [category_name] => 
            [tag] => 
            [cat] => 
            [tag_id] => 
            [author] => 
            [author_name] => 
            [feed] => 
            [tb] => 
            [paged] => 0
            [meta_key] => 
            [meta_value] => 
            [preview] => 
            [s] => 
            [sentence] => 
            [title] => 
            [fields] => 
            [menu_order] => 
            [embed] => 
            [category__in] => Array
                (
                )

            [category__not_in] => Array
                (
                )

            [category__and] => Array
                (
                )

            [post__in] => Array
                (
                )

            [post__not_in] => Array
                (
                )

            [post_name__in] => Array
                (
                )

            [tag__in] => Array
                (
                )

            [tag__not_in] => Array
                (
                )

            [tag__and] => Array
                (
                )

            [tag_slug__in] => Array
                (
                )

            [tag_slug__and] => Array
                (
                )

            [post_parent__in] => Array
                (
                )

            [post_parent__not_in] => Array
                (
                )

            [author__in] => Array
                (
                )

            [author__not_in] => Array
                (
                )

            [search_columns] => Array
                (
                )

            [ignore_sticky_posts] => 
            [suppress_filters] => 
            [cache_results] => 1
            [update_post_term_cache] => 1
            [update_menu_item_cache] => 
            [lazy_load_term_meta] => 1
            [update_post_meta_cache] => 1
            [nopaging] => 
            [comments_per_page] => 50
            [no_found_rows] => 
            [order] => 
        )

    [tax_query] => WP_Tax_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => AND
            [table_aliases:protected] => Array
                (
                )

            [queried_terms] => Array
                (
                )

            [primary_table] => wp_posts
            [primary_id_column] => ID
        )

    [meta_query] => WP_Meta_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => 
            [meta_table] => 
            [meta_id_column] => 
            [primary_table] => 
            [primary_id_column] => 
            [table_aliases:protected] => Array
                (
                )

            [clauses:protected] => Array
                (
                )

            [has_or_relation:protected] => 
        )

    [date_query] => 
    [request] => SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
					 FROM wp_posts 
					 WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
					 
					 ORDER BY RAND()
					 LIMIT 0, 3
    [posts] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 4439
                    [post_author] => 3
                    [post_date] => 2024-07-30 15:29:07
                    [post_date_gmt] => 2024-07-30 19:29:07
                    [post_content] => 

CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

Read more about IAMBIC and their recent funding here.

[post_title] => IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-08-09 15:38:43 [post_modified_gmt] => 2024-08-09 19:38:43 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [1] => WP_Post Object ( [ID] => 4437 [post_author] => 4 [post_date] => 2024-05-31 15:10:00 [post_date_gmt] => 2024-05-31 19:10:00 [post_content] =>

Congratulations to Dr. Carol A. Carter, SUNY Distinguished Professor in the Department of Microbiology and Immunology at the Stony Brook University Renaissance School of Medicine (RSOM), who was recently elected aa a member of the U.S. National Academy of Sciences (NAS.

The NAS is made up of the country’s leading researchers, who are elected in recognition of their distinguished and continuing achievements in original research. Election is considered one of the highest honors that a scientist can receive.

Dr. Carter is best known as an early pioneer in HIV research. At the onset of the AIDS pandemic, she advanced understanding of the viral-encoded protease and purified the viral capsid protein for structural and biochemical studies. She has also conducted research on Epstein-Barr Virus (EBV) and Severe Acute Respiratory Syndrome Coronavirus Virus-2 (SARS CoV-2), pathogens causing organ transplant rejection and COVID-19, respectively.

The Center for Biotechnology has had supported Dr. Carter's interests in exploring the potential commercial applications of her research through our NIH-REACH program and Long Island Bioscience Hub (LIBH).

Read more about Dr. Carter's work and her recent nomination here.

[post_title] => Dr. Carol A. Carter Elected to U.S. National Academy of Sciences [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => dr-carol-a-carter-elected-to-u-s-national-academy-of-sciences [to_ping] => [pinged] => [post_modified] => 2024-08-09 15:10:32 [post_modified_gmt] => 2024-08-09 19:10:32 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4437 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 2971 [post_author] => 4 [post_date] => 2018-05-15 15:18:07 [post_date_gmt] => 2018-05-15 15:18:07 [post_content] => The Long Island BioMentor Initiative (LIBMI) officially accepted its first program applications in a “launch event” at the de Seversky Mansion on Thursday May 10, 2018. Already a year into a “pilot phase,” the LIBMI was developed in league with the Massachusetts Institute of Technology’s Venture Mentoring Service which employs an “objective team-mentoring model” for early-stage businesses that champions one strict rule above all others: The uber-qualified mentors are prohibited from investing in, pitching business to or otherwise profiting from their mentees. Read the full article from Innovate Long Island. [post_title] => “Heavy-Hitting LI BioMentor Initiative Makes It Official” [post_excerpt] => The Long Island BioMentor Initiate (LIBMI) officially “launches” at an event held at the de Seversky Mansion on Thursday May 10, 2018. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => heavy-hitting-li-biomentor-initiative-makes-it-official [to_ping] => [pinged] => [post_modified] => 2019-01-25 14:48:57 [post_modified_gmt] => 2019-01-25 14:48:57 [post_content_filtered] => [post_parent] => 0 [guid] => http://centerforbiotechnology.org/?p=2971 [menu_order] => 122 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [3] => WP_Post Object ( [ID] => 3545 [post_author] => 3 [post_date] => 2020-05-12 11:45:44 [post_date_gmt] => 2020-05-12 11:45:44 [post_content] => In response to the ongoing COVID-19 situation, Brex has compiled a list of resources to help support the Life Sciences industry during this health crisis. Their most recently published eGuide highlights fundraising strategies for life science companies in the current landscape. PDF available here: Fundraising eGuide for Life Science Companies [post_title] => Fundraising eGuide for Life Science Companies [post_excerpt] => Brex's recently published eGuide highlights fundraising strategies for life science companies in the current landscape. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => fundraising-eguide-for-life-science-companies [to_ping] => [pinged] => [post_modified] => 2020-05-12 11:45:44 [post_modified_gmt] => 2020-05-12 11:45:44 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3545 [menu_order] => 67 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 4 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 4439 [post_author] => 3 [post_date] => 2024-07-30 15:29:07 [post_date_gmt] => 2024-07-30 19:29:07 [post_content] =>

CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.

The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.

Read more about IAMBIC and their recent funding here.

[post_title] => IAMBIC Receives $1 Million NSF SBIR Phase II Grant [post_excerpt] => This substantial funding from NSF enables IAMBIC to scale its operations. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => iambic-receives-1-million-nsf-sbir-phase-ii-grant [to_ping] => [pinged] => [post_modified] => 2024-08-09 15:38:43 [post_modified_gmt] => 2024-08-09 19:38:43 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4439 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 260 [max_num_pages] => 87 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) )

IAMBIC Receives $1 Million NSF SBIR Phase II Grant

More Information

Dr. Carol A. Carter Elected to U.S. National Academy of Sciences

More Information

“Heavy-Hitting LI BioMentor Initiative Makes It Official”

More Information

Fundraising eGuide for Life Science Companies

More Information